Prevention of Infections During Primary Immunodeficiency
Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce,...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2014-11, Vol.59 (10), p.1462-1470 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1470 |
|---|---|
| container_issue | 10 |
| container_start_page | 1462 |
| container_title | Clinical infectious diseases |
| container_volume | 59 |
| creator | Aguilar, Claire Malphettes, Marion Donadieu, Jean Chandesris, Olivia Coignard-Biehler, Hélène Catherinot, Emilie Pellier, Isabelle Stephan, Jean-Louis Le Moing, Vincent Barlogis, Vincent Suarez, Felipe Gérart, Stéphane Lanternier, Fanny Jaccard, Arnaud Consigny, Paul-Henri Moulin, Florence Launay, Odile Lecuit, Marc Hermine, Olivier Oksenhendler, Eric Picard, Capucine Blanche, Stéphane Fischer, Alain Mahlaoui, Nizar Lortholary, Olivier |
| description | Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce, practices are heterogeneous. To homogenize practices among centers, the French National Reference Center for PIDs aimed at elaborating recommendations for anti-infectious prophylaxis for the most common PIDs. We performed a literature review of infectious complications and prophylactic regimens associated with the most frequent PIDs. Then, a working group including different specialists systematically debated about chemoprophylaxis, immunotherapy, immunization, and recommendations for patients. Grading of prophylaxis was done using strength of recommendations (decreasing from A to D) and evidence level (decreasing from I to III). These might help infectious diseases specialists in the management of PIDs and improving the outcome of patients with PIDs. |
| doi_str_mv | 10.1093/cid/ciu646 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_pasteur_02454019v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>24032322</jstor_id><sourcerecordid>24032322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-8362a3fb4db12fdffa24dd981b350581ab64953cd3f8a63132b44ee5db5290893</originalsourceid><addsrcrecordid>eNpd0EtrFTEYBuAgir3oxr0yUAoijObL7STLUi89cMAudB0yuWgOM8kxmSn035syxxZchCTk4ePNi9AbwB8BK_rJRtfWIph4hk6B000vuILn7Yy57Jmk8gSd1brHGEBi_hKdEA6EYQGnSN4Wf-fTHHPqcui2KXj7cKnd56XE9Ku7LXEy5b7bTtOSsvMh2uiTvX-FXgQzVv_6uJ-jn1-__Li-6Xffv22vr3a9ZRuYe0kFMTQMzA1AggvBEOackjBQ3tKBGQRTnFpHgzSCAiUDY95zN3CisFT0HPXr3N9m1Ic1jM4m6purnT6YOvulaEwYZxjUHTT_fvWHkv8svs56itX6cTTJ56VqECDYZiM4b_TiP7rPS0ntN00RIhRwoE19WJUtudbiw2MKwPqhf93612v_Db87jlyGybtH-q_wBi6PwFRrxlBMsrE-OakYF5I093Z1-zrn8vTOMCWUEPoXT1OVzA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1622691513</pqid></control><display><type>article</type><title>Prevention of Infections During Primary Immunodeficiency</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Aguilar, Claire ; Malphettes, Marion ; Donadieu, Jean ; Chandesris, Olivia ; Coignard-Biehler, Hélène ; Catherinot, Emilie ; Pellier, Isabelle ; Stephan, Jean-Louis ; Le Moing, Vincent ; Barlogis, Vincent ; Suarez, Felipe ; Gérart, Stéphane ; Lanternier, Fanny ; Jaccard, Arnaud ; Consigny, Paul-Henri ; Moulin, Florence ; Launay, Odile ; Lecuit, Marc ; Hermine, Olivier ; Oksenhendler, Eric ; Picard, Capucine ; Blanche, Stéphane ; Fischer, Alain ; Mahlaoui, Nizar ; Lortholary, Olivier</creator><creatorcontrib>Aguilar, Claire ; Malphettes, Marion ; Donadieu, Jean ; Chandesris, Olivia ; Coignard-Biehler, Hélène ; Catherinot, Emilie ; Pellier, Isabelle ; Stephan, Jean-Louis ; Le Moing, Vincent ; Barlogis, Vincent ; Suarez, Felipe ; Gérart, Stéphane ; Lanternier, Fanny ; Jaccard, Arnaud ; Consigny, Paul-Henri ; Moulin, Florence ; Launay, Odile ; Lecuit, Marc ; Hermine, Olivier ; Oksenhendler, Eric ; Picard, Capucine ; Blanche, Stéphane ; Fischer, Alain ; Mahlaoui, Nizar ; Lortholary, Olivier</creatorcontrib><description>Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce, practices are heterogeneous. To homogenize practices among centers, the French National Reference Center for PIDs aimed at elaborating recommendations for anti-infectious prophylaxis for the most common PIDs. We performed a literature review of infectious complications and prophylactic regimens associated with the most frequent PIDs. Then, a working group including different specialists systematically debated about chemoprophylaxis, immunotherapy, immunization, and recommendations for patients. Grading of prophylaxis was done using strength of recommendations (decreasing from A to D) and evidence level (decreasing from I to III). These might help infectious diseases specialists in the management of PIDs and improving the outcome of patients with PIDs.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciu646</identifier><identifier>PMID: 25124061</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Oxford: OXFORD UNIVERSITY PRESS</publisher><subject>Agammaglobulinemia ; Biological and medical sciences ; Chronic granulomatous disease ; Communicable Disease Control ; Communicable Diseases ; Communicable Diseases - etiology ; Disease management ; Fungal infections ; Human health and pathology ; Humans ; Immune system ; IMMUNOCOMPROMISED HOSTS ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunoglobulins ; Immunologic Deficiency Syndromes ; Immunologic Deficiency Syndromes - complications ; Immunologic Deficiency Syndromes - diagnosis ; Immunology ; Immunopathology ; Immunotherapy ; Infection - etiology ; Infection Control ; Infections ; Infectious diseases ; Influenza vaccines ; Life Sciences ; Measles mumps rubella vaccines ; Medical disorders ; Medical sciences ; Physiological immunosuppression ; Pneumococcal vaccines ; Pre-Exposure Prophylaxis ; Preventive medicine ; Yellow fever vaccines</subject><ispartof>Clinical infectious diseases, 2014-11, Vol.59 (10), p.1462-1470</ispartof><rights>Copyright © 2014 Oxford University Press on behalf of the Infectious Diseases Society of America</rights><rights>2015 INIST-CNRS</rights><rights>The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</rights><rights>Copyright Oxford University Press, UK Nov 15, 2014</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-8362a3fb4db12fdffa24dd981b350581ab64953cd3f8a63132b44ee5db5290893</citedby><cites>FETCH-LOGICAL-c471t-8362a3fb4db12fdffa24dd981b350581ab64953cd3f8a63132b44ee5db5290893</cites><orcidid>0000-0001-9645-3968 ; 0000-0002-4491-1063 ; 0000-0003-2574-3874 ; 0000-0002-3537-9052 ; 0000-0001-8788-5056 ; 0000-0003-3242-7247 ; 0000-0002-8600-8454 ; 0000-0001-8588-7138 ; 0000-0002-9888-2528 ; 0000-0002-8325-8060</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/24032322$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/24032322$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28945682$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25124061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://pasteur.hal.science/pasteur-02454019$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Aguilar, Claire</creatorcontrib><creatorcontrib>Malphettes, Marion</creatorcontrib><creatorcontrib>Donadieu, Jean</creatorcontrib><creatorcontrib>Chandesris, Olivia</creatorcontrib><creatorcontrib>Coignard-Biehler, Hélène</creatorcontrib><creatorcontrib>Catherinot, Emilie</creatorcontrib><creatorcontrib>Pellier, Isabelle</creatorcontrib><creatorcontrib>Stephan, Jean-Louis</creatorcontrib><creatorcontrib>Le Moing, Vincent</creatorcontrib><creatorcontrib>Barlogis, Vincent</creatorcontrib><creatorcontrib>Suarez, Felipe</creatorcontrib><creatorcontrib>Gérart, Stéphane</creatorcontrib><creatorcontrib>Lanternier, Fanny</creatorcontrib><creatorcontrib>Jaccard, Arnaud</creatorcontrib><creatorcontrib>Consigny, Paul-Henri</creatorcontrib><creatorcontrib>Moulin, Florence</creatorcontrib><creatorcontrib>Launay, Odile</creatorcontrib><creatorcontrib>Lecuit, Marc</creatorcontrib><creatorcontrib>Hermine, Olivier</creatorcontrib><creatorcontrib>Oksenhendler, Eric</creatorcontrib><creatorcontrib>Picard, Capucine</creatorcontrib><creatorcontrib>Blanche, Stéphane</creatorcontrib><creatorcontrib>Fischer, Alain</creatorcontrib><creatorcontrib>Mahlaoui, Nizar</creatorcontrib><creatorcontrib>Lortholary, Olivier</creatorcontrib><title>Prevention of Infections During Primary Immunodeficiency</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce, practices are heterogeneous. To homogenize practices among centers, the French National Reference Center for PIDs aimed at elaborating recommendations for anti-infectious prophylaxis for the most common PIDs. We performed a literature review of infectious complications and prophylactic regimens associated with the most frequent PIDs. Then, a working group including different specialists systematically debated about chemoprophylaxis, immunotherapy, immunization, and recommendations for patients. Grading of prophylaxis was done using strength of recommendations (decreasing from A to D) and evidence level (decreasing from I to III). These might help infectious diseases specialists in the management of PIDs and improving the outcome of patients with PIDs.</description><subject>Agammaglobulinemia</subject><subject>Biological and medical sciences</subject><subject>Chronic granulomatous disease</subject><subject>Communicable Disease Control</subject><subject>Communicable Diseases</subject><subject>Communicable Diseases - etiology</subject><subject>Disease management</subject><subject>Fungal infections</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Immune system</subject><subject>IMMUNOCOMPROMISED HOSTS</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunoglobulins</subject><subject>Immunologic Deficiency Syndromes</subject><subject>Immunologic Deficiency Syndromes - complications</subject><subject>Immunologic Deficiency Syndromes - diagnosis</subject><subject>Immunology</subject><subject>Immunopathology</subject><subject>Immunotherapy</subject><subject>Infection - etiology</subject><subject>Infection Control</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza vaccines</subject><subject>Life Sciences</subject><subject>Measles mumps rubella vaccines</subject><subject>Medical disorders</subject><subject>Medical sciences</subject><subject>Physiological immunosuppression</subject><subject>Pneumococcal vaccines</subject><subject>Pre-Exposure Prophylaxis</subject><subject>Preventive medicine</subject><subject>Yellow fever vaccines</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0EtrFTEYBuAgir3oxr0yUAoijObL7STLUi89cMAudB0yuWgOM8kxmSn035syxxZchCTk4ePNi9AbwB8BK_rJRtfWIph4hk6B000vuILn7Yy57Jmk8gSd1brHGEBi_hKdEA6EYQGnSN4Wf-fTHHPqcui2KXj7cKnd56XE9Ku7LXEy5b7bTtOSsvMh2uiTvX-FXgQzVv_6uJ-jn1-__Li-6Xffv22vr3a9ZRuYe0kFMTQMzA1AggvBEOackjBQ3tKBGQRTnFpHgzSCAiUDY95zN3CisFT0HPXr3N9m1Ic1jM4m6purnT6YOvulaEwYZxjUHTT_fvWHkv8svs56itX6cTTJ56VqECDYZiM4b_TiP7rPS0ntN00RIhRwoE19WJUtudbiw2MKwPqhf93612v_Db87jlyGybtH-q_wBi6PwFRrxlBMsrE-OakYF5I093Z1-zrn8vTOMCWUEPoXT1OVzA</recordid><startdate>20141115</startdate><enddate>20141115</enddate><creator>Aguilar, Claire</creator><creator>Malphettes, Marion</creator><creator>Donadieu, Jean</creator><creator>Chandesris, Olivia</creator><creator>Coignard-Biehler, Hélène</creator><creator>Catherinot, Emilie</creator><creator>Pellier, Isabelle</creator><creator>Stephan, Jean-Louis</creator><creator>Le Moing, Vincent</creator><creator>Barlogis, Vincent</creator><creator>Suarez, Felipe</creator><creator>Gérart, Stéphane</creator><creator>Lanternier, Fanny</creator><creator>Jaccard, Arnaud</creator><creator>Consigny, Paul-Henri</creator><creator>Moulin, Florence</creator><creator>Launay, Odile</creator><creator>Lecuit, Marc</creator><creator>Hermine, Olivier</creator><creator>Oksenhendler, Eric</creator><creator>Picard, Capucine</creator><creator>Blanche, Stéphane</creator><creator>Fischer, Alain</creator><creator>Mahlaoui, Nizar</creator><creator>Lortholary, Olivier</creator><general>OXFORD UNIVERSITY PRESS</general><general>Oxford University Press</general><general>Oxford University Press (OUP)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-9645-3968</orcidid><orcidid>https://orcid.org/0000-0002-4491-1063</orcidid><orcidid>https://orcid.org/0000-0003-2574-3874</orcidid><orcidid>https://orcid.org/0000-0002-3537-9052</orcidid><orcidid>https://orcid.org/0000-0001-8788-5056</orcidid><orcidid>https://orcid.org/0000-0003-3242-7247</orcidid><orcidid>https://orcid.org/0000-0002-8600-8454</orcidid><orcidid>https://orcid.org/0000-0001-8588-7138</orcidid><orcidid>https://orcid.org/0000-0002-9888-2528</orcidid><orcidid>https://orcid.org/0000-0002-8325-8060</orcidid></search><sort><creationdate>20141115</creationdate><title>Prevention of Infections During Primary Immunodeficiency</title><author>Aguilar, Claire ; Malphettes, Marion ; Donadieu, Jean ; Chandesris, Olivia ; Coignard-Biehler, Hélène ; Catherinot, Emilie ; Pellier, Isabelle ; Stephan, Jean-Louis ; Le Moing, Vincent ; Barlogis, Vincent ; Suarez, Felipe ; Gérart, Stéphane ; Lanternier, Fanny ; Jaccard, Arnaud ; Consigny, Paul-Henri ; Moulin, Florence ; Launay, Odile ; Lecuit, Marc ; Hermine, Olivier ; Oksenhendler, Eric ; Picard, Capucine ; Blanche, Stéphane ; Fischer, Alain ; Mahlaoui, Nizar ; Lortholary, Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-8362a3fb4db12fdffa24dd981b350581ab64953cd3f8a63132b44ee5db5290893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Agammaglobulinemia</topic><topic>Biological and medical sciences</topic><topic>Chronic granulomatous disease</topic><topic>Communicable Disease Control</topic><topic>Communicable Diseases</topic><topic>Communicable Diseases - etiology</topic><topic>Disease management</topic><topic>Fungal infections</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Immune system</topic><topic>IMMUNOCOMPROMISED HOSTS</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunoglobulins</topic><topic>Immunologic Deficiency Syndromes</topic><topic>Immunologic Deficiency Syndromes - complications</topic><topic>Immunologic Deficiency Syndromes - diagnosis</topic><topic>Immunology</topic><topic>Immunopathology</topic><topic>Immunotherapy</topic><topic>Infection - etiology</topic><topic>Infection Control</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza vaccines</topic><topic>Life Sciences</topic><topic>Measles mumps rubella vaccines</topic><topic>Medical disorders</topic><topic>Medical sciences</topic><topic>Physiological immunosuppression</topic><topic>Pneumococcal vaccines</topic><topic>Pre-Exposure Prophylaxis</topic><topic>Preventive medicine</topic><topic>Yellow fever vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aguilar, Claire</creatorcontrib><creatorcontrib>Malphettes, Marion</creatorcontrib><creatorcontrib>Donadieu, Jean</creatorcontrib><creatorcontrib>Chandesris, Olivia</creatorcontrib><creatorcontrib>Coignard-Biehler, Hélène</creatorcontrib><creatorcontrib>Catherinot, Emilie</creatorcontrib><creatorcontrib>Pellier, Isabelle</creatorcontrib><creatorcontrib>Stephan, Jean-Louis</creatorcontrib><creatorcontrib>Le Moing, Vincent</creatorcontrib><creatorcontrib>Barlogis, Vincent</creatorcontrib><creatorcontrib>Suarez, Felipe</creatorcontrib><creatorcontrib>Gérart, Stéphane</creatorcontrib><creatorcontrib>Lanternier, Fanny</creatorcontrib><creatorcontrib>Jaccard, Arnaud</creatorcontrib><creatorcontrib>Consigny, Paul-Henri</creatorcontrib><creatorcontrib>Moulin, Florence</creatorcontrib><creatorcontrib>Launay, Odile</creatorcontrib><creatorcontrib>Lecuit, Marc</creatorcontrib><creatorcontrib>Hermine, Olivier</creatorcontrib><creatorcontrib>Oksenhendler, Eric</creatorcontrib><creatorcontrib>Picard, Capucine</creatorcontrib><creatorcontrib>Blanche, Stéphane</creatorcontrib><creatorcontrib>Fischer, Alain</creatorcontrib><creatorcontrib>Mahlaoui, Nizar</creatorcontrib><creatorcontrib>Lortholary, Olivier</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aguilar, Claire</au><au>Malphettes, Marion</au><au>Donadieu, Jean</au><au>Chandesris, Olivia</au><au>Coignard-Biehler, Hélène</au><au>Catherinot, Emilie</au><au>Pellier, Isabelle</au><au>Stephan, Jean-Louis</au><au>Le Moing, Vincent</au><au>Barlogis, Vincent</au><au>Suarez, Felipe</au><au>Gérart, Stéphane</au><au>Lanternier, Fanny</au><au>Jaccard, Arnaud</au><au>Consigny, Paul-Henri</au><au>Moulin, Florence</au><au>Launay, Odile</au><au>Lecuit, Marc</au><au>Hermine, Olivier</au><au>Oksenhendler, Eric</au><au>Picard, Capucine</au><au>Blanche, Stéphane</au><au>Fischer, Alain</au><au>Mahlaoui, Nizar</au><au>Lortholary, Olivier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of Infections During Primary Immunodeficiency</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2014-11-15</date><risdate>2014</risdate><volume>59</volume><issue>10</issue><spage>1462</spage><epage>1470</epage><pages>1462-1470</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce, practices are heterogeneous. To homogenize practices among centers, the French National Reference Center for PIDs aimed at elaborating recommendations for anti-infectious prophylaxis for the most common PIDs. We performed a literature review of infectious complications and prophylactic regimens associated with the most frequent PIDs. Then, a working group including different specialists systematically debated about chemoprophylaxis, immunotherapy, immunization, and recommendations for patients. Grading of prophylaxis was done using strength of recommendations (decreasing from A to D) and evidence level (decreasing from I to III). These might help infectious diseases specialists in the management of PIDs and improving the outcome of patients with PIDs.</abstract><cop>Oxford</cop><pub>OXFORD UNIVERSITY PRESS</pub><pmid>25124061</pmid><doi>10.1093/cid/ciu646</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9645-3968</orcidid><orcidid>https://orcid.org/0000-0002-4491-1063</orcidid><orcidid>https://orcid.org/0000-0003-2574-3874</orcidid><orcidid>https://orcid.org/0000-0002-3537-9052</orcidid><orcidid>https://orcid.org/0000-0001-8788-5056</orcidid><orcidid>https://orcid.org/0000-0003-3242-7247</orcidid><orcidid>https://orcid.org/0000-0002-8600-8454</orcidid><orcidid>https://orcid.org/0000-0001-8588-7138</orcidid><orcidid>https://orcid.org/0000-0002-9888-2528</orcidid><orcidid>https://orcid.org/0000-0002-8325-8060</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2014-11, Vol.59 (10), p.1462-1470 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_pasteur_02454019v1 |
| source | Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Agammaglobulinemia Biological and medical sciences Chronic granulomatous disease Communicable Disease Control Communicable Diseases Communicable Diseases - etiology Disease management Fungal infections Human health and pathology Humans Immune system IMMUNOCOMPROMISED HOSTS Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunoglobulins Immunologic Deficiency Syndromes Immunologic Deficiency Syndromes - complications Immunologic Deficiency Syndromes - diagnosis Immunology Immunopathology Immunotherapy Infection - etiology Infection Control Infections Infectious diseases Influenza vaccines Life Sciences Measles mumps rubella vaccines Medical disorders Medical sciences Physiological immunosuppression Pneumococcal vaccines Pre-Exposure Prophylaxis Preventive medicine Yellow fever vaccines |
| title | Prevention of Infections During Primary Immunodeficiency |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20Infections%20During%20Primary%20Immunodeficiency&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Aguilar,%20Claire&rft.date=2014-11-15&rft.volume=59&rft.issue=10&rft.spage=1462&rft.epage=1470&rft.pages=1462-1470&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1093/cid/ciu646&rft_dat=%3Cjstor_hal_p%3E24032322%3C/jstor_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1622691513&rft_id=info:pmid/25124061&rft_jstor_id=24032322&rfr_iscdi=true |